| Solid fat nanoemulsions as drug delivery vehicles S Amselem, D Friedman US Patent 5,576,016, 1996 | 315 | 1996 |
| A new method for preparation of phospholipid vesicles (liposomes)‐french press Y Barenholzt, S Amselem FEBS letters 99 (1), 210-214, 1979 | 239 | 1979 |
| Submicron emulsions for delivery of peptides D Friedman, J Schwarz, S Amselem US Patent 5,514,670, 1996 | 210 | 1996 |
| Solid fat nanoemulsions S Amselem, D Friedman US Patent 5,662,932, 1997 | 207 | 1997 |
| Submicron emulsions as vaccine adjuvants GH Lowell, S Amselem, D Friedman, H Aviv US Patent 5,961,970, 1999 | 178 | 1999 |
| Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin A Gabizon, R Chisin, S Amselem, S Druckmann, R Cohen, D Goren, ... British Journal of Cancer 64 (6), 1125-1132, 1991 | 172 | 1991 |
| Bioadhesive emulsion preparations for enhanced drug delivery D Friedman, J Schwarz, S Amselem US Patent 5,993,846, 1999 | 167 | 1999 |
| Solid coprecipitates for enhanced bioavailability of lipophilic substances S Amselem US Patent 5,891,469, 1999 | 162 | 1999 |
| Optimization and upscaling of doxorubicin-containing liposomes for clinical use S Amselem, Y Barenholz, A Gabizon Journal of pharmaceutical sciences 79 (12), 1045-1052, 1990 | 161 | 1990 |
| Quality control assays in the development and clinical use of liposome-based formulations Y Barenholz, S Amselem Liposome technology 1, 527-616, 1993 | 154 | 1993 |
| Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study A Gabizon, T Peretz, A Sulkes, S Amselem, R Ben-Yosef, N Ben-Baruch, ... European Journal of Cancer and Clinical Oncology 25 (12), 1795-1803, 1989 | 151 | 1989 |
| Bioadhesive emulsion preparations for enhanced drug delivery D Friedman, J Schwartz, S Amselem US Patent 5,744,155, 1998 | 139 | 1998 |
| Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability S Amselem US Patent 5,989,583, 1999 | 138 | 1999 |
| Polyanhydrides: synthesis and characterization AJ Domb, S Amselem, J Shah, M Maniar Biopolymers I, 93-141, 1993 | 119 | 1993 |
| Suspension of loteprednol etabonate for ear, eye, or nose treatment S Amselem, D Friedman US Patent 5,747,061, 1998 | 117 | 1998 |
| Stability of liposomal doxorubicin formulations: problems and prospects Y Barenholz, S Amselem, D Goren, R Cohen, D Gelvan, A Samuni, ... Medicinal research reviews 13 (4), 449-491, 1993 | 108 | 1993 |
| Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages JN Verma, M Rao, S Amselem, U Krzych, CR Alving, SJ Green, ... Infection and immunity 60 (6), 2438-2444, 1992 | 103 | 1992 |
| Degradable polymers for site‐specific drug delivery A Domb, S Amselem, J Shah, M Maniar Polymers for Advanced Technologies 3 (6), 279-292, 1992 | 98 | 1992 |
| Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA … GH Lowell, RW Kaminski, TC VanCott, B Slike, K Kersey, E Zawoznik, ... Journal of Infectious Diseases 175 (2), 292-301, 1997 | 85 | 1997 |
| Submicron emulsions as drug carriers for topical administration S Amselem, D Friedman Submicron emulsions in drug targeting and delivery, 153-174, 2019 | 68 | 2019 |
